HomeComparePXCLY vs PFE

PXCLY vs PFE: Dividend Comparison 2026

PXCLY yields 1097.69% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PXCLY wins by $42670934.66M in total portfolio value
10 years
PXCLY
PXCLY
● Live price
1097.69%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42670934.70M
Annual income
$36,186,112,381,019.42
Full PXCLY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PXCLY vs PFE

📍 PXCLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPXCLYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PXCLY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PXCLY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PXCLY
Annual income on $10K today (after 15% tax)
$93,304.06/yr
After 10yr DRIP, annual income (after tax)
$30,758,195,523,866.51/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PXCLY beats the other by $30,758,195,501,546.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PXCLY + PFE for your $10,000?

PXCLY: 50%PFE: 50%
100% PFE50/50100% PXCLY
Portfolio after 10yr
$21335467.38M
Annual income
$18,093,056,203,639.07/yr
Blended yield
84.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PXCLY
No analyst data
Altman Z
-0.2
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PXCLY buys
0
PFE buys
0
No recent congressional trades found for PXCLY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPXCLYPFE
Forward yield1097.69%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$42670934.70M$49.6K
Annual income after 10y$36,186,112,381,019.42$26,258.71
Total dividends collected$42181654.88M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PXCLY vs PFE ($10,000, DRIP)

YearPXCLY PortfolioPXCLY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$120,469$109,769.48$9,153$693.39+$111.3KPXCLY
2$1,364,778$1,235,875.99$8,593$849.25+$1.36MPXCLY
3$14,545,387$13,085,074.18$8,336$1,066.78+$14.54MPXCLY
4$145,896,918$130,333,353.78$8,437$1,384.80+$145.89MPXCLY
5$1,377,888,627$1,221,778,925.33$9,013$1,875.40+$1377.88MPXCLY
6$12,258,265,620$10,783,924,788.62$10,306$2,680.72+$12258.26MPXCLY
7$102,778,253,910$89,661,909,696.59$12,820$4,101.38+$102778.24MPXCLY
8$812,553,753,569$702,581,021,885.76$17,673$6,826.70+$812553.74MPXCLY
9$6,060,581,611,005$5,191,149,094,686.17$27,543$12,591.86+$6060581.58MPXCLY
10$42,670,934,704,795$36,186,112,381,019.42$49,560$26,258.71+$42670934.66MPXCLY

PXCLY vs PFE: Complete Analysis 2026

PXCLYStock

Phoenix Copper Limited engages in the exploration and mining activities for precious and base metals primarily in North America. The company explores for copper, zinc, gold, lead, tungsten, cobalt, and silver deposits. It owns 80% interest in the Empire Mine property. The company also holds 100% interest in the Redcastle property consisting 30 unpatented claims covering an area of approximately 600 acres, and Bighorn property consisting 29 unpatented claims covering 580 acres located in Idaho; Red Star project located in Mackay, Idah; and Navarre Creek property covering 2,420 acres located in Custer County, Idaho. The company was formerly known as Phoenix Global Mining Limited and changed its name to Phoenix Copper Limited in July 2019. Phoenix Copper Limited was incorporated in 2013 and is based in Road Town, British Virgin Islands.

Full PXCLY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PXCLY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PXCLY vs SCHDPXCLY vs JEPIPXCLY vs OPXCLY vs KOPXCLY vs MAINPXCLY vs JNJPXCLY vs MRKPXCLY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.